Coya Therapeutics, Common Stock Analysis

Coya Stock Analysis Notes

About 20.0% of the company shares are held by institutions such as insurance companies. The book value of Coya Therapeutics, was currently reported as 2.1. The company recorded a loss per share of 0.65. Coya Therapeutics, Common had not issued any dividends in recent years. For more info on Coya Therapeutics, Common please contact the company at 800 587 8170 or go to https://www.coyatherapeutics.com.

Coya Therapeutics, Common Investment Alerts

Coya Therapeutics, Common Upcoming and Recent Events

Coya Largest EPS Surprises

View All Earnings Estimates

Coya Therapeutics, Environmental, Social, and Governance (ESG) Scores

Coya Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 108.6 M.

Coya Profitablity

The company has Profit Margin (PM) of (1.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.17) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.17.

Management Efficiency

Coya Therapeutics, Common has return on total asset (ROA) of (0.2934) % which means that it has lost $0.2934 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5083) %, meaning that it created substantial loss on money invested by shareholders. Coya Therapeutics,'s management efficiency ratios could be used to measure how well Coya Therapeutics, manages its routine affairs as well as how well it operates its assets and liabilities. As of November 23, 2024, Return On Tangible Assets is expected to decline to -0.2. In addition to that, Return On Capital Employed is expected to decline to -0.23. At present, Coya Therapeutics,'s Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 43.3 M, whereas Net Tangible Assets are projected to grow to (14.7 M).

Technical Drivers

As of the 23rd of November, Coya Therapeutics, shows the Mean Deviation of 3.81, risk adjusted performance of 0.0409, and Downside Deviation of 6.23. Coya Therapeutics, Common technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Coya Therapeutics, Common Price Movement Analysis

Coya Therapeutics, Common Insider Trading Activities

Coya Therapeutics, Predictive Daily Indicators

Coya Therapeutics, Corporate Filings

Coya Therapeutics, Forecast Models

Coya Therapeutics,'s time-series forecasting models are one of many Coya Therapeutics,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Coya Therapeutics,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Coya Therapeutics, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Coya shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Coya Therapeutics,. By using and applying Coya Stock analysis, traders can create a robust methodology for identifying Coya entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Coya analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Coya analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Coya Therapeutics, Common stock analysis indicators help investors evaluate how Coya Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Coya Therapeutics, shares will generate the highest return on investment. By understating and applying Coya Therapeutics, stock analysis, traders can identify Coya Therapeutics, position entry and exit signals to maximize returns.

When running Coya Therapeutics,'s price analysis, check to measure Coya Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coya Therapeutics, is operating at the current time. Most of Coya Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Coya Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coya Therapeutics,'s price. Additionally, you may evaluate how the addition of Coya Therapeutics, to your portfolios can decrease your overall portfolio volatility.